Key Developments: Bruker Corp (BRKR.O)
16.94USD
22 May 2013
$-0.42 (-2.42%)
$17.36
$17.35
$17.35
$16.79
1,493,546
887,485
$19.46
$9.91
Latest Key Developments (Source: Significant Developments)
Bruker Corp Lowers FY 2013 Guidance
Bruker Corp updated fiscal 2013 guidance and expects reported revenue growth rates by approximately 2% due to the recent Yen depreciation. This reduction is expected to result in reported revenue growth of 2% to 3% for fiscal 2013. The Company now expects to report fiscal 2013 non-GAAP EPS of between $0.80 and $0.83, a reduction of $0.08 from previous guidance, also due primarily to the weaker Yen. The Company reported revenue of $1.791 billion in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $1.87 billion and EPS of $0.90 for fiscal 2103. Full Article
Bruker Corp Issues FY 2013 Guidance; Revenue Guidance Above Analysts' Estimates; Issues Q1 2013 Guidance; EPS Guidance Below Analysts' Estimates-Conference Call
Bruker Corp announced that for fiscal 2013, it expects expect to generate reported revenue growth of approximately 4% to 5% and expect to generate approximately 6% to 10% growth in non-GAAP earnings per share in fiscal 2013 when compared to fiscal 2012. In addition, in fiscal 2013, the Company expect to incur $20 million to $25 million of restructuring charges related to the facility exits in CAM and BEST and the rampup of its outsourcing initiatives in other divisions. For the first quartet of 2013, it expects modest revenue growth and non-GAAP EPS could even slightly decline from first quarter 2012 levels. The Company reported revenue of $1.791 billion and EPS of $0.83 for fiscal 2012; and revenue of $405.60 million and EPS of $0.14 for the first quarter of 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $1.858 billion and EPS of $0.90 for fiscal 2013; and revenue of $419.17 million and EPS of $0.16 for the first quartet of 2013. Full Article
Bruker Corp and Erasmus Medical Center Sign Exclusive Licensing Agreement
Bruker Corp announced an exclusive licensing agreement with Erasmus Medical Center, Rotterdam, The Netherlands for rapid testing of beta-lactamase activity using MALDI-TOF technology. This new method is fully compatible with the well-established Bruker MALDI Biotyper system, which is used for MALDI-TOF mass spectrometry-based identification of microorganisms in over 700 clinical and non-clinical microbiology laboratories worldwide. Full Article
Bruker Corp Receives Over $7 Million in SP9900+ 3D Optical Microscope Orders
Bruker Corp announced that it has received more than $7 million in orders for its new Bruker SP9900+ high-throughput high density interconnect (HDI) substrate metrology system, and has begun shipping the product in volume. Full Article
Bruker Corp Wins Over $3 Million In Orders For Consumer Display Solution
Bruker Corp announced that it has received over $3 million in orders from a provider of consumer displays for Bruker`s self-calibrating ContourGT-X 3D optical microscopes. Full Article
Bruker Corp Raises FY 2012 Guidance
Bruker Corp announced that as a result of third quarter performance, it is raising fiscal 2012 revenue guidance to a range of $1.73-$1.76 billion, and also raising fiscal 2012 adjusted EPS guidance to $0.75-$0.79 per diluted share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $1.73 billion and EPS of $0.67 for fiscal 2012. Full Article
Bruker Corp Lowers FY 2012 Revenue Guidance; Issues FY 2012 EPS Guidance Below Analysts' Estimates
Bruker Corp announced that given softening demand in certain key markets, and the lower than expected profitability of the Company in the first six months of 2012, the Company is re-evaluating business plans for the second half of 2012. Accordingly, it is reducing previously announced fiscal 2012 financial goals. The Company updated financial goals for fiscal 2012, which replace all previously announced goals, and expects revenue of $1.70-$1.75 billion and adjusted EPS of $0.65-$0.70. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $1.76 billion and EPS of $0.81 for fiscal 2012. Full Article
Bruker Corp Issues Q2 2012 Guidance Below Analysts' Estimates
Bruker Corp announced that for the second quarter of 2012, it expects revenue of approximately $420 million, GAAP EPS in the range of $0.05-$0.07 and adjusted EPS in the range of $0.11-$0.13. The Company's financial results in the second quarter of 2012 were adversely impacted by a weaker Euro, softening customer demand, especially in Europe, and an increase in spending. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $435 million and EPS of $0.21 for the second quarter of 2012. Full Article
Bruker Corp Issues FY 2012 Revenue Guidance In Line With Analysts' Estimates-Conference Call
Bruker Corp announced that for fiscal 2012, it expects a 7% to 10% currency-adjusted revenue growth that will result in $1.76-$1.81 billion. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $1.80 billion for fiscal 2012. Full Article
Bruker Corp Appoints Charles F. Wagner, Jr. as Executive Vice President and New Chief Financial Officer
Bruker Corp announced the appointment of Charles F. Wagner, Jr. as its Executive Vice President (EVP) and new Chief Financial Officer (CFO), effective on or about June 30, 2012. William J. Knight, the Company's current CFO, will continue to serve as a member of the Company’s senior management team and will work with Mr. Wagner to ensure a smooth transition of his responsibilities as CFO. Since August 2010, Mr. Wagner has been a member of the Company's Board of Directors and a member of the Audit Committee of the Board, roles that he stepped down from effective June 4, 2012. Chris van Ingen, an independent director of the Company, has been elected to serve on the Audit Committee as of June 4, 2012. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
